Help
RSS
API
Feed
Maltego
Contact
Domain > beyondantibody.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2026-02-01
103.21.59.165
(
ClassC
)
Port 80
HTTP/1.1 200 OKDate: Mon, 05 Aug 2024 02:03:10 GMTServer: nginx/1.23.4Content-Type: text/htmlVary: Accept-EncodingX-Server-Cache: trueX-Proxy-Cache: EXPIREDTransfer-Encoding: chunked !DOCTYPE HTML>html>head> title>Beyond Antibody/title> meta namedescription contentBeyond Antibody Website /> meta namekeywords contentbiologics, biopharma, assay development, immunogenicity, in vitro assay, in vivo assay, biophysical /> meta http-equivcontent-type contenttext/html; charsetwindows-1252 /> link relstylesheet typetext/css hrefhttp://fonts.googleapis.com/css?familyTangerine&v1 /> link relstylesheet typetext/css hrefhttp://fonts.googleapis.com/css?familyYanone+Kaffeesatz /> link relstylesheet typetext/css hrefstyle/style.css />/head>body> div idmain> div idheader> div idlogo> a href/>img srcimages/BAlogo_t.gif ALTBeyond Antibody>/a> div classslogan>Your biologics development partner/div> /div> div idsite_content> div idsidebar_container> img classpaperclip srcstyle/paperclip.png altpaperclip /> div classsidebar> !-- insert your sidebar items here --> h3>Latest news on Biologics/h3> h4>EMA approves Insulin Glargine Biosimilar/h4> h5>18 November 2016/h5> p>EMA-CHMP announces marketing authorization of biosimilar Insulin Glargine of Merck, to be known as Lusduna. This will be the second Glargine biosimilar approved by EMA. br />a hrefhttp://www.gabionline.net/Biosimilars/News/EMA-approves-biosimilars-of-insulin-glargine-and-teriparatide target_blank>Read more/a>/p> h4>Amgen submits biosimlar application for Bevacizumab/h4> h5>16 Novmber 2016/h5> p>Amgen and Allergan announced submission of a BLA to US FDA for ABP 215, a biosimilar candidate to Avastin (Bevacizumab). br />a hrefhttp://www.biosimilarnews.com/amgen-and-allergan-submit-bevacizumab-biosimilar-application-to-us-fda target_blank>Read more/a>/p> /div>img classpaperclip srcstyle/paperclip.png altpaperclip/> div classsidebar> h3>Contact us/h3> p>Write to us at a hrefmailto:info@beyondantibody.com>info@beyondantibody.com/a> for more details about our services./p>p> You can also call us
Port 443
HTTP/1.1 200 OKDate: Mon, 05 Aug 2024 02:03:11 GMTServer: nginx/1.23.4Content-Type: text/htmlAccept-Ranges: bytesVary: Accept-EncodingX-Server-Cache: trueX-Proxy-Cache: MISSTransfer-Encoding: chunked !DOCTYPE HTML>html>head> title>Beyond Antibody/title> meta namedescription contentBeyond Antibody Website /> meta namekeywords contentbiologics, biopharma, assay development, immunogenicity, in vitro assay, in vivo assay, biophysical /> meta http-equivcontent-type contenttext/html; charsetwindows-1252 /> link relstylesheet typetext/css hrefhttp://fonts.googleapis.com/css?familyTangerine&v1 /> link relstylesheet typetext/css hrefhttp://fonts.googleapis.com/css?familyYanone+Kaffeesatz /> link relstylesheet typetext/css hrefstyle/style.css />/head>body> div idmain> div idheader> div idlogo> a href/>img srcimages/BAlogo_t.gif ALTBeyond Antibody>/a> div classslogan>Your biologics development partner/div> /div> div idsite_content> div idsidebar_container> img classpaperclip srcstyle/paperclip.png altpaperclip /> div classsidebar> !-- insert your sidebar items here --> h3>Latest news on Biologics/h3> h4>EMA approves Insulin Glargine Biosimilar/h4> h5>18 November 2016/h5> p>EMA-CHMP announces marketing authorization of biosimilar Insulin Glargine of Merck, to be known as Lusduna. This will be the second Glargine biosimilar approved by EMA. br />a hrefhttp://www.gabionline.net/Biosimilars/News/EMA-approves-biosimilars-of-insulin-glargine-and-teriparatide target_blank>Read more/a>/p> h4>Amgen submits biosimlar application for Bevacizumab/h4> h5>16 Novmber 2016/h5> p>Amgen and Allergan announced submission of a BLA to US FDA for ABP 215, a biosimilar candidate to Avastin (Bevacizumab). br />a hrefhttp://www.biosimilarnews.com/amgen-and-allergan-submit-bevacizumab-biosimilar-application-to-us-fda target_blank>Read more/a>/p> /div>img classpaperclip srcstyle/paperclip.png altpaperclip/> div classsidebar> h3>Contact us/h3> p>Write to us at a hrefmailto:info@beyondantibody.com>info@beyondantibody.com/a> for more details about our services./p>p> You can also call us
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]